Clinical Trials in Medical Rehabilitation

Recently published federal rules and requirements for clinical trials

  • Clinical Trial Requirements for Grants and Contracts
    NIH is launching a series of initiatives that are rolling out in 2017-2018 to enhance the accountability and transparency of clinical research. These initiatives target key points along the whole clinical trial lifecycle from concept to results reporting. Learn more about these changes and how they will affect your research.
  • Federal Policy for the Protection of Human Subjects (Published January 19, 2017)
    The U.S. Department of Health and Human Services (HHS) and fifteen other Federal Departments and Agencies announced revisions to modernize, strengthen, and make more effective the Federal Policy for the Protection of Human Subjects that was originally promulgated as a Common Rule in 1991. This final rule is intended to better protect human subjects involved in research, while facilitating valuable research and reducing burden, delay, and ambiguity for investigators. These revisions are an effort to modernize, simplify, and enhance the current system of oversight.
  • Policy Supporting the Next Generation Researchers Initiative (NOT-OD-17-101) (Published August 31, 2017)
    This policy amends the definitions of, and policies supporting, early stage investigators (ESIs). In addition, it creates a new policy for early established investigators (EEIs), previously referred to as mid-career investigators, and describes how NIH will monitor the implementation of the policy to determine the impact on ESI and EEI diversity in the NIH portfolio.

NIA Clinical Research Study Investigator's Toolbox

This tool box provides researchers and their study teams with a central source of materials to plan studies, incorporate consistent processes, collect accurate data, and maintain appropriate safety oversight.

NIH Reporter

Learn about active NIH funded medical rehabilitation research projects.

Access the list on the NIH RePORT website.

Recently published on ClinicalTrials.gov

September 11, 2017
A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps
Condition:   Nasal Polyps, Chronic Sinusitis
Interventions:   Drug: Omalizumab;   Drug: Placebo
Sponsor:   Hoffmann-La Roche
Not yet recruiting - verified September 2017
September 11, 2017
A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps
Condition:   Nasal Polyps, Chronic Rhinosinusitis
Interventions:   Drug: Omalizumab;   Drug: Placebo
Sponsor:   Hoffmann-La Roche
Not yet recruiting - verified September 2017
View all on ClinicalTrials.gov

The University of Alabama at Birmingham
1313 13th Street South, OSB 3rd Floor
Birmingham, AL 35205
Telephone: (205) 934-3706

© 2017. All rights reserved.